Abstract Chemical genetics is an emerging field that can be used to study the interactions of chemical compounds, including natural products, with proteins. Usually, the identification of molecular targets is the starting point for studying a drug's mechanism of action and this has been a crucial step in understanding many biological processes. While a great variety of target identification methods have been developed over the last several years, there are still many bioactive compounds whose target proteins have not yet been revealed because no routine protocols can be adopted. This review contains information concerning the most relevant principles of chemical genetics with special emphasis on the different genomic and proteomic approaches used in forward chemical genetics to identify the molecular targets of the bioactive compounds, the advantages and disadvantages of each and a detailed list of successful examples of molecular targets identified with these approaches.
Introduction
Despite advances made in combinatorial chemistry techniques (Lebl 1999) and high throughput screening (HTS) (Fox et al. 1999) by the pharmaceutical industry which have provided a greater number of novel chemical compounds and related biological data (Oprea 2002) , the number of new drugs developed or under clinical trial has not increased proportionately (Bronson et al. 2011; Danishefsky 2010; Drews 2000; Gaudillière et al. 2001; Horrobin 2000) .
Modern medicinal chemistry is focused on the study of protein-small molecule interactions and gene functionalities encoding protein synthesis (Stockwell 2004) . Many of the medicinally relevant proteins have already been identified and in this connection the sequencing of the human genome (Drews 2000; Witkowski 2010 ) has helped scientists to identify Electronic supplementary material The online version of this article (doi:10.1007/s11101-013-9312-6) contains supplementary material, which is available to authorized users. therapeutic targets and tackle the diseases facing humanity. However, elucidation of bioactive compound mechanisms of action is the major problem in chemical biology (Kwok et al. 2006 ) since most cellular targets of bioactive compounds have yet to be revealed. Natural products (NPs) are now increasingly being used as probes in the systematic search of inhibitors for key biochemical pathways and to delve further into the study of biological systems (Carlson 2010) . The efficient identification of the chemical compounds that modulate protein functions both in vivo and in vitro is at the heart of research in chemical biology and medicinal chemistry.
Small molecules (SM) are essential as drugs in modern medicine and are valuable as probes to explore relevant biological processes. However, new approaches are needed to close the wide gap between the ability to study either single proteins or whole cellular processes. So, it is of interest to focus on studies designed to understand in more detail how SM disrupt particular signalling pathways and larger networks to yield distinct cellular phenotypes (Castoreno and Eggert 2011).
Chemical genetics
Chemical biology includes study and research of the interface between chemistry and biology (Altmann et al. 2009 ). In this context, chemical biology is aimed at studying the interactions of chemical compounds, including NPs, with proteins, to identify their role in biological processes (Schreiber 2003) .
The above definition of chemical biology complements classical genetics where the focus is also on finding targets and signalling pathways. Chemical genetics can be defined simply as a genetic study using chemical tools (Schreiber 1998) . Chemical genetics uses chemical compounds that may specifically activate or inhibit one or more target proteins (Chang 2009; Spring 2005) . It offers several advantages over its classical counterpart and allows the study of unexplored biological space. For example, genes essential for survival or development cannot be studied using classical genetics; this can only be done using chemical genetics. Thus, the instantaneous effects of SM can be characterized using chemical genetics (Chang 2009; Walsh and Chang 2006 ). It also makes it possible to study mammals whereas classical genetic techniques are more complicated to apply due to their diploid genome, physical size and slow reproduction rate (Chang 2009 ). Other benefits of using chemical compounds are the temporal control and reversibility of the inhibition of protein function (Hübel et al. 2008) .
As in classical genetics, two approaches can be taken to chemical genetics ( Fig. 1) (Das et al. 2011) : Forward chemical genetics (Chang 2009; Burdine and Kodadek 2004) and reverse chemical genetics (Blackwell and Zhao 2003; Neumann et al. 2003) .
In forward chemical genetics, typical random mutagenesis is replaced by a screening of a library of typically not targeted SMs against multiple potential targets simultaneously (Chang 2009) . Compounds that induce a phenotype of interest can be selected and then the target protein of this compound is identified. Forward chemical genetics require three components (Lokey 2003) : (a) a collection or library of chemical compounds (chemical toolbox generation); (b) a biological assay with a quantifiable phenotypic output, usually performed using living cells or complex cellular extracts by means of the cyclobot method (Mendoza et al. 1999; Stockwell et al. 1999) and (c) a strategy to join an active compound to its biological target, otherwise known as target identification.
In reverse chemical genetics, a known target protein is screened using SM libraries to identify functional ligands that either stimulate or inhibit the target protein. Once a specific ligand that produces a change in the protein function is identified, it is introduced into a cell or organism and the resulting changes in the phenotype are studied (Chang 2009 (Spring 2005) . Today, target identification is one of the greatest challenges in forward chemical genetics. Recent progress and difficulties in this field and different methods for the identification of biological targets will be discussed in depth in this review.
Approaches to the biological target identification in forward chemical genetics
Once a SM that induces a certain phenotypic response in a cell culture or in vivo experiment has been identified, the elucidation of it biological target is one of the greatest technical challenges in forward chemical genetics and phenotype-based drug discovery. The determination of these targets is particularly important in understanding the mode of action of potential SM and of various biological processes under study since a large number of drugs have multiple intracellular targets, some of which may be responsible for the undesirable side effects of the drugs. Therefore, identification of relevant targets can often lead to the discovery of more specific drugs with fewer side effects (Campillos et al. 2008) . Furthermore, once a target protein is identified, its functions and cellular signalling pathways can be elucidated thus facilitating drug discovery research. However, no routine protocols can be adopted for the identification of molecular targets due to the great structural diversity of NPs.
Over the last several years a great variety of target identification methods have been developed, ranging from biochemical to genetic, which have received a number of excellent reviews (Das et al. 2011; Hübel et al. 2008; Leslie and Hergenrother 2008; Roti and Stegmaier 2012; Sleno and Emili 2008; Terstappen et al. 2007 ). We will classify these approaches as: affinitybased methods, genetic methods and other methods.
Affinity-based target identification methods
Traditionally, affinity-based methods play a major role in the identification of molecular targets for many biologically-active SM and NPs. These methods detect the direct binding of the SM to its target(s) and almost all successful affinity experiment have involved the combination of high affinity molecules with a high abundance of target proteins such as the isolation of FKBP12 (FK-506 binding protein-12) using the compound FK506 (Harding et al. 1989 ).
However, it is possible to isolate a high abundance target protein with a low-affinity SM since, although interaction affinity is low, the abundance of the target proteins enable identification, a case in hand being the isolation of human GLO1 (glyoxalase 1) as a secondary target of the anti-inflammatory SM indomethacin (Sato et al. 2007 ).
We will classify the affinity-based target identification methods in the following groups: Matrix-based affinity methods: Affinity chromatography; Matrixfree affinity methods: Affinity by fluorescence, radioactivity, photoaffinity or immunoaffinity; Methods based on the stability of the target in response to its affinity for the drug (DARTS); Mass spectrometrybased affinity techniques and stability of proteins of rates of oxidation (SPROX).
Matrix-based affinity methods: affinity chromatography
Affinity chromatography is the oldest and most widely and successful used approach (Guiffant et al. 2007; Katayama and Oda 2007; Sakamoto et al. 2012; Sato et al. 2010) . In this method a SM of interest is modified by introducing a suitable functional group (linker) through which it can be immobilized by attachment to a solid support (matrix) followed by the addition of a protein extract. Matrix-based methods should fulfil three requisites: (a) that the SM contains a derivatizable function, (b) that SM retains at least part of their activity after the derivatization and (c) that the matrix does not hinder the binding of the target protein to the SM (Lomenick et al. 2009 ). The latter two conditions cannot be predicted a priori and sometimes the SM cannot be provided or synthesized in sufficient amounts for the study.
First of all, it is necessary to know through a structure-activity relationship study which functional groups can be modified and used as points of attachment to the solid support through a linker. The linker type has a bearing on the success of obtaining the target proteins and is crucial for diminishing nonspecific binding proteins. An optimal chemical linker should be mildly hydrophobic so as to prevent autoaggregation and also must be long enough to prevent steric hindrance between the SM and the target protein ( Fig. 2) (Sato et al. 2010) .
Recent advances in this field to enhance the efficiency of affinity purification have been performed Phytochem Rev (2013) 12:895-914 897 and in this connection we would highlight the following linkers: (a) Hydrophilic linkers with PEG units (Bach et al. 2005; Furuya et al. 2006; Jung et al. 2005; Sato et al. 2007; Tamura et al. 2003; Zhang et al. 2007) or tartaric acid derivatives (Shiyama et al. 2004) to reduce non-specific binding proteins; (b) ACAP linkers (aminocaproylaminopentyloxy) to reduce auto-aggregation resulting from its optimal length, hydrophobicity and greater rigidity (Guiffant et al. 2007 ) and (c) elongation of the anterior linkers by insertion of a rigid polyproline helix for the isolation of low abundance or low affinity proteins. An example of this is the isolation of GLO1 as a new target of indomethacin (Sato et al. 2007) . SMs are immobilized to the matrix by means of complementary functional groups between the matrix and the linker. Traditionally, sugar-based affinity matrices such as agarose or Sepharose have been used in this approach, Affigel Ò matrices being one of the most popular affinity matrices; however, these matrices are unstable in organic solvents and also cause non-specific binding of proteins (Sakamoto et al. 2012 ). These problems can be solved by using resinbased affinity matrices due to their stability both in organic and aqueous media, physical and chemical stability and high ligand loading capacity. Matrices based on polymethacrylate derivatives have been developed as an alternative to Affigel Ò matrices, with special mention of the matrices known as Toyopearl.
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Nevertheless, these matrices often show a high number of non-specific binding proteins by comparison with Affigel Ò matrices (Sakamoto et al. 2012 ). Alternatively, it is possible to immobilize SMs directly onto the resin using capturable molecules such as biotin (Fig. 3) , which are easily trapped by avidinagarose columns (McPherson et al. 2002) . The strong non-covalent interaction between biotin and avidin results in the essentially non-reversible loading of the SM onto the resin (Hofmann and Kiso 1976; Hofmann et al. 1978) . This approach has been used to identify the mitochondrial enzyme OAT (ornithine d aminotransferase) as the target protein of the antimitotic marine diazonamide A (Wang et al. 2007) .
Once the SM is immobilized on a suitable solid support it is incubated with a cell lysate or protein extract, usually by passing the extract through a column of immobilized material followed by extensive washing to remove non-specific binding proteins. Finally, the tightly bound proteins are eluted with an excess of free molecule or under strongly denaturing conditions using an electrophoresis buffer. These proteins are analysed by SDS-PAGE 1D (sodium dodecyl sulphate polyacrylamide gel electrophoresis), extracted from the gel and the protein bands are identified by mass spectrometry after partial tryptic digestion and databases are then searched for comparison of mass-sequencing of the digested peptides (Fig. 4) .
On the other hand, as mentioned above, isolation and identification of target proteins by means of affinity chromatography is a difficult task because of the non-specific adsorption of background protein to the resin and linker. Therefore, several approaches have been used in order to differentiate between specific and non-specific interactions.
First of all, it is important to carry out well-designed negative control experiments. One approach is to use an inactive analogue of the SM with physical properties similar to the active SM (Sato et al. 2010; Snyder et al. 2005; Wang et al. 2007 ). In this regard, an inactive chiral isomer or seco-analogue of the active molecule would serve as an excellent negative control (Sato et al. 2010 ) by comparison of proteins eluted between the active molecule and the inactive analogue. An example is the identification of the target protein of diazonamide A using a seco-analogue of this SM (Wang et al. 2007 ).
Nevertheless, sometimes inactive structural analogues are not available for such study and different alternative strategies have been developed such as competitive elution experiments (Emami et al. 2004; Ito et al. 2010; Sleno and Emili 2008) and serial affinity chromatography (Yamamoto et al. 2006) .
Competitive elution of bound proteins using an excess of free SM would permit selective elution under mild conditions; however, the SM's low water solubility is a hurdle that needs to be addressed in this approach. To this end, some hydrophilic organic solvents such as DMSO have been used to improve the water solubility of the SM (Sakamoto et al. 2012) . One successful example of selective elution is the isolation of a cyclic AMP response element-binding protein as a molecular target of ICG-001, a SM that downregulates signalling by b-catenin/T cell factor (Emami et al. 2004) .
Last, an alternate serial affinity chromatography approach has been reported where the protein extract is applied to the immobilized ligand matrix which is subsequently removed. The fresh matrix is then incubated with the same lysate (Yamamoto et al. 2006 ). The first matrix should capture most of the specific binding proteins due to their high affinity for the SM while the same amount of non-specific background proteins should be captured by both matrices. This approach has been used to identify the target proteins of FK506, benzenesulphonamide and methotrexate (Yamamoto et al. 2006 ) (see Table 1 supporting information).
A great number of small-molecules whose targets have been identified or confirmed by this approach are depicted in Table 1 of the supporting information, which highlights currently the success and widespread for this approach.
Matrix-free affinity methods
Matrix-free affinity methods rely on the incorporation of affinity tags to the SM of interest. An affinity tag can be defined as a compound that imparts an additional function to the SM to which it is attached. Like matrixbased affinity methods, the SM must be derivatizable and maintain at least part of its biological activity. The most important affinity tags are the fluorophores and photoreactive groups.
Fluorescence In this approach, the SM bound to proteins can be visualized in fluorescence gels and the fluorescence bands identified by mass spectrometry (Fig. 5) . Furthermore, the introduction of a fluorophore to a SM can reveal the subcellular location of the target proteins. To that end, appropriate lysates with an enrichment of the target protein can be used reducing the background levels in protein purification. An example is the isolation of SF3b as a molecular target of pladienolide B (Kotake et al. 2007 ).
One of the most frequently used and studied fluorophores is the jellyfish green fluorescent protein (GFP) (Tsien 1998; Zhang et al. 2002) . However, the major drawback of GFP is its huge size (239 amino acids), sometimes diminishing the activity of the SM to which it binds.
An alternative is the use of styryl dyes (Garrett and Fattaey 1999; Sridhar et al. 2000) , which span a broad range of fluorescent emission wavelengths, or the use of acylphenols as a transfer agent for immunoaffinity fluorescent tags (IAF) (Hughes et al. 2009 ).
Some examples of target proteins identified by fluorescence-based affinity are shown in Table 2 of the supporting information.
Photoaffinity This approach is commonly used when the SM has moderate or low affinity for its target protein(s) (Sadakane and Hatanaka 2006) . In order to bind the SM irreversibly to its target protein a crosslinking reagent can be used to prevent the dissociation of weak binders (Leslie and Hergenrother 2008) . In a photoaffinity experiment, a SM with a photoreactive functional tag and a reporter tag is added to a lysate or whole cell. The reporter tag is usually a radioactive isotope (MacKinnon et al. 2007) or biotin which enables the isolation and identification of target proteins. In the absence of UV light, the interaction between the SM and target protein takes place because the photoreactive group is stable while irradiation of the photoreactive group at a specific wavelength will generate a carbene that can produce the covalent attachment of the SM to the protein target (Leslie and Hergenrother 2008) . Labelled protein mixtures are separated by denaturing-gel electrophoresis and detected with a phosphorimager. Specifically labelled proteins are then isolated and subjected to limited proteolytic digestion and identified by mass spectrometry (Fig. 6 ) (Dormán and Prestwich 2000) .
A drawback of this approach is that the SM must retain biological activity after derivatization with a photoreactive group. The most frequently used photophores are benzophenones, (Dormán and Prestwich 1994) aryl azides (Fleming 1995; Kotzyba-Hibert et al. 1995) and diazirines (Brunner 1993 ). However, their large size can potentially interfere with SM/protein interactions. Recently, photo-leucine has been used as a photophore because of its smaller alkyl diazirine side chains (MacKinnon et al. 2007 ). In order to maximize the efficiency of photo cross-linking they incorporated an alkyne tag instead of biotin to perform an azidealkyne cyclo-addition known as ''click chemistry'' (Cohen et al. 2007; Speers and Cravatt 2004) .
Examples of successful target identification by this approach are shown in Table 3 of the supporting information.
Drug affinity responsive target stability (DARTS)
Most of affinity-based approaches described above require derivatization of the SM of interest and it is not always possible to maintain its biological activity. In order to overcome this obstacle, a target identification method known as DARTS has been recently developed where any SM library can be used without chemical derivatization or labelling (Lomenick et al. 2009 , Lomenick et al. 2011 Nishiya et al. 2009) .
DARTS is based on the notion that if a SM binds to its target protein, the protein-SM complex would be less susceptible to proteolysis. If the SM is not present, Fig. 6 Scheme of a photoaffinity experiment a protease detects its recognition site(s) on the target surface initiating a proteolytic attack that leads to the complete digestion of the target protein.
In this approach, it is not necessary to know the structure of the SM, and NP extracts can be used (Lomenick et al. 2011) . Furthermore, whereas other affinity-based approaches utilize positive enrichment by selectively assembling the target proteins of the SMs, DARTS uses negative enrichment by digesting non-target proteins while leaving behind the target proteins which are resistant to proteases. In a DARTS experiment, a SM incubated with a protein lysate and a control protein sample are each treated with varying amounts of protease and separated by 1D SDS-PAGE. Then, the bands whose abundance differs between the two samples are removed, treated with trypsin and analysed by mass spectrometry (Fig. 7) (Lomenick et al. 2011) .
However, many target proteins can be missed in this approach because it is necessary to visualize the enrichment of the target protein in the gel (Lomenick et al. 2011) . In order to solve this difficulty, different proteomic approaches have been performed to increase the sensitivity and throughput of this method, some of which can also be applied to other target identification methods. Special mention should be made of the development of 2D-PAGE (O'Farrell 1975) , analysis of multiple samples by difference gel electrophoresis (DIGE) (Unlu et al. 1997 ) and advances in multidimensional protein identification technology (MudPIT) (Washburn et al. 2001) .
Another drawback of this approach is the type of protease chosen which is crucial to maximize the digestion of all non-target proteins without compromising the protection of the target protein. Currently, protease mixtures are used and good results are being obtained with Pronase (Roche), a commercially available protease mixture capable of digesting both native and unfolded proteins (Lomenick et al. 2011) .
If these drawbacks are solvent, DARTS could be an alternative to affinity chromatography in the coming years. Small-molecules whose targets have been identified or confirmed by this approach are summarized in Table 4 of the supporting information.
Stability of proteins from rates of oxidation (SPROX)
This affinity-based label-free approach is also based on thermodynamic measurements (West et al. 2010 ). In comparison with DARTS, the folding and thermodynamic stability of the target proteins are also studied but uses the ligand-induced changes in the methionine oxidation levels for target proteins as the readout (Lomenick et al. 2011) . From an experimental standpoint, a cell lysate is studied in both the absence and presence of SM. Both samples are treated with increasing concentrations of guanidinium hydrochloride, a chemical denaturant, and the same amount of H 2 O 2 in order to selectively oxidize the thioether groups in the side chain of methionine residues. Finally, a quantitative proteomic analysis is performed and the target proteins are identified by a change in protein stability since both samples are identical (West et al. 2010) .
On the other hand, a disadvantage of SPROX is the fact that only the most abundant proteins in each sample can be identified and accurately quantified because there is no a target protein enrichment mechanism (Lomenick et al. 2011) . But the biggest drawback of SPROX is that the target proteins must have a methionine-containing peptide and not all methionine residues have different oxidation rates whereby to determine thermodynamic changes (Roti and Stegmaier 2012) . Some examples of target proteins identified by means of this approach are shown in Table 5 of supporting information.
Activity-based protein profiling (ABPP)
This approach is based on the response of reactive functional groups (mainly electrophiles) of SMs with catalytic residues in the enzyme's active site (Liu et al. 1999; Sadaghiani et al. 2007 ). The SMs are comprised of a reactive group, a linker and a tag. Radioactive groups, fluorophores such as rhodamine and biotin can be used as tags to visualize and purify labelled proteins (Cravatt et al. 2008) . Covalent modification can occur directly using a highly nucleophilic active site residue or by incorporation of a photoreactive group (i.e. benzophenone) followed by UV irradiation (Sleno and Emili 2008) .
The protein targets for bioactive SMs are identified by comparing the labelling reduction when a compound is present (Fig. 8) (Sleno and Emili 2008) . The addition of a SM, either in solution or in vivo, makes the inhibited target protein(s) less available to subsequent labelling.
The major advantage of ABPP is the fact that allow the targeted enzymes to be labelled for purification and analysis; However, it is necessary the derivatization of each SM which must contain reactive functional groups.
Small-molecule probes have been successfully used for the identification of proteases, lipases, cytochrome P-450s, glycosidases, kinases and phosphatases (Heal et al. 2011; Nomura et al. 2010; Simon and Cravatt 2010) .
Mass spectrometry-based proteomic approaches
Quantitative proteomics have proven to be a powerful tool for discriminating between protein-SM specific interactions from background interactions in affinity experiments (Cheng et al. 2010) . Nevertheless, the absolute intensity of a peptide in a mass spectrum depends, among other factors, on the type of ionization thus calling for the use of internal standards. The ideal internal standard should be a peptide of identical sequence but labelled with different stable isotopes. Hence, several strategies based on stable isotope labelling such as ICAT (isotope-coded affinity tag) (Gygi et al. 1999; Han et al. 2001; Oda et al. 2003) , iTRAQ (isobaric relative and absolute tag for quantification) (DeSouza et al. 2005; Rix and Superti-Furga 2009; Ross et al. 2004 ) and SILAC (stable isotope labelling by amino acid in cell culture) (Ong et al. 2002 , Ong et al. 2009 Yan and Chen 2005) have been developed for quantitative proteome analysis. The SILAC approach exploits the ability of live cells to incorporate labelled amino acids through media supplementation. Proteins will incorporate either ''light'', natural isotope abundance forms, or the ''heavy'', 13 C and 15 N-bearing versions of arginine and lysine amino acids (Ong et al. 2002) . Protein lysates from cultures are incubated either SM-loaded beads and soluble SM competitor or SM-bead alone. Then, the samples are combined, separated by SDS-PAGE and analyzed by mass spectrometry. Proteins interacting directly with the SM will be enriched in the heavy state over the light and will be identified by differential ratios. Non-specific interactions of proteins will be enriched equally in both states and will have the same isotopic ratio (Fig. 9) (Ong et al. 2009 ).
The molecular targets of several kinase inhibitors have been identified by SILAC (Ong et al. 2009 ) (see Table 6 supporting information).
A disadvantage of this method is that requires at least five populations to satisfactorily incorporate the isotopic labels and can only be used with biological samples grown in culture (Ong et al. 2003; Yan and Chen 2005 ). An alternative is the ICAT technique which is a gel-free approach enabling the quantification of proteins in any biological system (Roti and Stegmaier 2012) . This approach uses a chemical reagent containing a biotin affinity tag for selective purification, a linker that incorporates stable isotopes and an iodoacetamide reactive group that specifically reacts with cysteinyl thiols (Yan and Chen 2004) . In an ICAT experiment, a protein lysate incubated with the SM bound to an affinity matrix and the same lysate incubated with a molecule control are labelled in vitro with heavy (d8) and light (d0) ICAT reagents, respectively (Fig. 10) . Then, both protein mixtures are combined, digested with trypsin into peptides and subjected to avidin affinity chromarography to enrich the labelled peptides that carry biotin tags in order to reduce the complexity of the mixtures. Finally, the labelled peptides are isolated, identified by their differences in the isotopic distribution and quantified using LC-MS.
Several target proteins of anticancer E7070 have been identified using this approach (Oda et al. 2003) .
Although the ICAT approach drastically reduces the complexity of the mixture, only 96 % of human proteome possesses cysteine residues (Zhang et al. 2004 ). To overcome this difficulty, an amine groupbased methodology known as iTRAQ has been developed by Ross et al. (2004) . This in vitro gelfree approach utilizes isobaric reagents composed of a reporter group, a balance group and a reactive group that reacts specifically with primary amine groups of peptides (Fig. 11) . The reporter group is a 4-methylpiperazinyl tag with a mass ranging from 114 to 117 Da according to the different isotopic Fig. 10 (Yan and Chen 2005) . In an iTRAQ experiment, a lysate incubated with the SM bound to an affinity matrix and the same lysate incubated with a molecule control are labelled in vitro each with a different iTRAQ reagent. Then, labelled peptides in both samples are combined and analyzed by LC-MS/MS and the target proteins are identified by their differences in the isotopic distribution (Fig. 11) .
Recently, a kinobead matrix has been developed to evaluate the selectivity of several kinases by iTRAQ (see Table 7 of the supporting information) (Bantscheff et al. 2007 ).
Genetic methods to identify the molecular target
Genetic-based methods study the SM targets/pathways from the physiological responses or biochemical signatures produced by the SMs (Lomenick et al. 2009 ). We classify the genetic-based methods into the following groups: expression-cloning-based methods (Terstappen et al. 2007 ), microarray technologies (Sleno and Emili 2008) , gene overexpression techniques (Luesch et al. 2005 ) and synthetic lethality approaches (Lum et al. 2004 ).
Expression-cloning-based methods
These approaches are based on the expression of target proteins from cDNA libraries. To solve the problems associated with the low abundance of target proteins, these methods include an affinity step to increase their quantity and facilitate their purification and isolation. Nevertheless, because the target proteins are expressed on the basis of fusion constructs of cDNA libraries, their properties might be different from those of their native counterparts and this could affect binding to the SM (Terstappen et al. 2007 ). Moreover, these methods are usually limited to yeast or other simple well-characterized model organisms.
The following approaches have been applied for the identification of target proteins: yeast and mammalian three hybrid systems, phage display, mRNA display and Drug westerns (Tanaka et al. 1999) .
Yeast three hybrid (Y3H) and mammalian three hybrid systems The use of yeasts is widely used for the identification of target proteins, being Saccharomyces cerevisiae an organism model of simple eukaryotes given that its genome can easily be manipulated (Bjornsti 2002; Forsburg 2001) .
Y3H is currently a promising approach for the identification of target proteins (Licitra and Liu 1996) , which is comprised of three components: a synthetic hybrid ligand and two hybrid fusion proteins. One of the hybrid fusion proteins is composed of a DNA binding domain (LexA) fused generally to dihydrofolate reductase (DHFR), a target of methotrexate (MTX), which acts as a ligand binding domain (Abida et al. 2002; Baker et al. 2003; Lin et al. 2000) . The   Fig. 11 Scheme of the iTRAQ approach other fusion protein contains a transcriptional activation domain, usually derived from the yeast transcription factor GAL4 (Henthorn et al. 2002) , fused to a cDNA library that includes the potential target proteins (Becker et al. 2004 ). The synthetic hybrid ligand is a SM that is covalently linked through a spacer to a ligand, usually MTX, in order to connect the first hybrid fusion protein to the second. From an experimental standpoint, a yeast strain that expresses DHFR is transformed with a library of cDNAs fused to a transcriptional activation domain. Then, the hybrid ligand is added to yeast and, if a binding protein is present in the library, the hybrid ligand will attach the transcriptional activation domain to the DNA activating expression of the reporter gene which is measured as the assay signal. Cells that express the reporter gene are selected and their DNA is extracted and sequenced in order to identify the potential target proteins by means of sequence-similarity searches (Fig. 12 ) (Becker et al. 2004) .
Successful examples of identification of target proteins by Y3H are shown in Table 8 of the supporting information.
Unlike other expression cloning approaches the interaction between SMs and target proteins occur in living cells (Terstappen et al. 2007 ). Nevertheless, this approach can not be used directly in mammals due to differences in regard to yeast proteins. In order to solve this limitation, the MASPIT system (Mammalian Small Molecule Protein Interaction Trap) has been developed (Caligiuri et al. 2006) . This is based on the associated JAK cytokine-receptor (janus-activated kinase)-STAT (signal transducer and activator of transcription) signal transduction system (Terstappen et al. 2007) .
One successful example of MASPIT system in mammals is the identification of ephrin receptor tyrosine kinases and cyclin G-associated kinase of the ABL tyrosine kinase inhibitor PD173955 (Fig. 13 ) (Caligiuri et al. 2006) .
mRNA display This approach utilizes mRNA display to identify proteins bound to a SM of interest (McPherson et al. 2002) . Amplification by PCR (polymerase chain reaction) (Fig. 14 step 1 ) of a cDNA library with primers that introduce sequences permits in vitro transcription ( Fig. 14 step 2) . Then, the mRNAs generated are ligated to a puromycin-DNA linker (Fig. 14 step 3 ) and the in vitro translation is carried out to generate protein-mRNA fusion molecules (Fig. 14 step 4) (Liu et al. 2000; Terstappen et al. 2007 ). The complexes obtained are purified and reverse transcribed to generate a stable cDNA template (Fig. 14 step 5) . Then, the biotinlabelled SMs of interest are immobilized on solid support and incubated with mRNA display molecules (Fig. 14 step 6) (Terstappen et al. 2007; Tochtrop and King 2004) . Binding proteins are purified using avidin chromarography by elution with free biotin. After elution of the binding proteins (Fig. 14 step 7) , the cDNAs are amplified by PCR (Fig. 14 step 1 ) resulting again in a cDNA library that is rich in target proteins. Finally, after several iteration processes, the cDNAs are purified, sequenced and the target protein identified by means of a DNA sequence similarity search (Hammond et al. 2001) .
The major advantage of this approach is that the amplification process should permit the identification of low abundance targets by repetitive rounds of affinity selection; however, iterative rounds of amplification may promote the identification of short-length products rather than their full-length counterparts (Terstappen et al. 2007) . To our knowledge, this method has only been successful with an immobilized conjugate of FK506-biotin to identify full-length FKBP12 (McPherson et al. 2002) .
Phage display This approach has emerged as a valid approach to identify target proteins of SMs using the display of proteins on bacteriophages such as M13, T4 and T7, which enable the extraction of proteins from large libraries whereby a cDNA library is expressed with bacteriophage coat proteins (Kay et al. 1996; Sche et al. 1999 ). The phage library obtained is then exposed to the biotinylated immobilized SM resulting in the capture of bacteriophages that have affinity for the SM (Fig. 15 step 1) (King 1999) . Next, an extensive wash is done to minimize non-specific interactions between some of the bacteriophage coat proteins and agarose column and the binding bacteriophages are eluted selectively with excess of biotin ( Fig. 15 step 2) and transfected into bacterial host cells (Fig. 15 step 3) (usually E. coli) for amplification ( Fig. 15 step 4) (Das et al. 2011; Terstappen et al. 2007 ). Phage populations obtained are re-exposed to immobilized SMs and are subjected to several rounds of affinity enrichment (Fig. 15 step  5) (Jung et al. 2009 ). Finally, a monoclonal phage population is obtained and the target proteins are identified by DNA sequence-similarity searches (Terstappen et al. 2007) .
In general, low-abundance targets and targets of low-affinity SM can be identified by iterative amplification steps; however, in practice is usually complicated because clones that express high-affinity proteins will dominate the phage population. Another disadvantage of this approach is the fact that it is necessary to use a labelled-SM. Several successful examples of target protein identification using this approach are shown in Table 9 of the supporting information.
Drug westerns Tagged SMs are used in this approach to electrophoretically probe cDNA expression libraries (Tanaka et al. 1999) . In this experiment, a plaque consisting of one member of a cDNA library is observed when bacteriophages are grown in a Petri dish together with the cDNA library (Chang 2009; Das et al. 2011) . Proteins from the plaque are transferred to a nitrocellulose membrane where they are screened against labelled SMs with an antigen (BSA or FITC). Hits obtained from the plaques are detected by enhanced chemiluminescence, a single virus is isolated and purified and the target proteins are identified by DNA sequencing method (Fig. 16) .
This method can facilitate immediate cloning of the genes encoding drug-binding proteins. However, as in other approaches, a limiting aspect of Drug westerns is the fact that a labelled SM is required.
An example of the application of Drug westerns method is the isolation of the transcription factor NF-YB and Thymosin b-10 as target proteins of the anticancer small molecule HMN-154 (Fig. 17) (Tanaka et al. 1999) .
Microarray technologies
Miniaturized high-density arrays with immobilized proteins or cDNA (microarrays) can be used in highthroughput assays in order to identify the targets of the SMs. Protein microarrays and DNA microarrays have been developed for this purpose.
Protein microarrays In this approach the binding profile of a SM for an entire proteome can easily be obtained in a short period of time (Sleno and Emili 2008; Terstappen et al. 2007) . A set of proteins are purified and immobilized by amino-terminal glutathione S-transferase (GST) tag on a glass microscope slide or some other derivatized surface (Heng et al. 2001; Heng and Snyder 2003) . The microarray is then incubated with a labelled form of the SM, usually biotin. After thorough washing, bound targets are detected by adding a streptavidin fluorescently labelled conjugate and then the labelled proteins are identified by their positions on the microarray. As a loading control, the microarray is probed with GST-specific antibodies (Fig. 18) (Sleno and Emili 2008; Terstappen et al. 2007) .
The major advantage of this method is that it allows for equal exposition of all proteins to the SM. Furthermore, proteins can be attached to chemically modified porous silicon and, after the addition of SMs, the bound substrates can be selectively monitored using techniques such as DIOS (direct ionization on silicon) (Shen et al. 2001) or MALDI-TOF.
Successful of this approach will be increased with the development of label-free binding detection compatible with the proteome array format.
On the other hand, this approach only reproduces the binding in vitro meaning that some proteins, whose affinity for the SM is due to post-translational modifications or their involvement in a complex formation with other proteins, might not be identified. Moreover, depending on the positioning of the protein on the chip, the SM might not bind to its target protein due to steric hindrance (Terstappen et al. 2007) .
Some successful examples of this approach are shown in Table 10 of supporting information.
DNA microarrays This approach, known as ''reverse transfected'' cell microarrays, is based on the expression of defined cDNAs avoiding the use of individually purified proteins (Ziauddin and Sabatini Phytochem Rev (2013) 12:895-914 907 2001) since the glass slides are imprinted with sets of specific cDNAs in expression vectors, overlaid with a transfection reagent and covered with mammalian cells in a culture medium. Transfected cells will express cDNAs at a defined location on the chip and the target proteins will be revealed by the addition of a fluorescent or radioisotope-labelled SM to the chip and subsequent DNA sequence-similarity searches ( Fig. 19 ) (Terstappen et al. 2007 ). The major disadvantage of this approach is that the sensitivity of detection might be compromised for some cell types since transfection efficiencies can be relatively slow (Terstappen et al. 2007 ).
FKBP12 has been identified by DNA microarrays when radiolabelled FK506 is added to the culture medium of HEK293T cells (Ziauddin and Sabatini 2001) .
Gene overexpression techniques
This technique is based on the principle that gene overexpression results in increased protein product, and if this protein is targeted by a SM, the cell should gain resistance to that SM (Luesch et al. 2005 ). This approach uses DNA libraries which are transformed by a yeast strain and the products obtained are grown on media containing the SM at a concentration that inhibits wild type growth. Target proteins are identified from drug-resistant transformants by means of sequencing of plasmid DNA (Fig. 20) (Bharucha and Kumar 2007) .
However, the main disadvantage of this approach is that SMs often exhibit lower permeability in yeast cells than in mammalian cells.
Several successful examples of target protein identification using this approach are shown in Table 11 of the supporting information. 
Synthetic lethality
This genetic approach uses collections of heterozygous mutants and studies their hypersensitivity to SMs (Giaever et al. 1999; Lum et al. 2004) . The availability of the genome-wide collection of heterozygous yeast deletion strains is allowing the systematic application of this methodology.
It is often assumed that the reduction of the gene copy number of a target protein can result in sensitization to the small molecule of interest. Genomic DNA from cultures before (G = 0) and after twenty generations of growth (G = 20) are isolated, amplified by PCR and hybridized to DNA microarrays (Tochtrop and King 2004) . Target proteins are identified by their ability to confer resistance to a strain when present at high copy (Fig. 21) .
This approach has the advantage that a free-label SM can be used.
However, hypersensitivity may can due both direct and indirect mechanism, so other techniques will be required in order to confirm the molecular target of each SM (Tochtrop and King 2004) . Moreover, only can be used SM that affect cell growth/viability.
Several successful examples of target identification using this approach are shown in Table 12 of the supporting information.
Other methods
Despite the fact that genetic and affinity-based methods have successfully contributed to the identification of a large number of target proteins, these methods cannot be applied in a general manner due the nature of each ligand and target protein and it is necessary to investigate and develop new methods for the elucidation of biological targets. In this section, we will discuss the identification of targets using different basis to those described above.
Biochemical suppression
This method is based on the functional suppression of protein activity by chemical inhibitors by in vitro reactions regardless of the affinity that the SM has for its target protein (Peterson et al. 2006; Terstappen et al. 2007) . From an experimental standpoint, an activity assay is used to measure the inhibition produced in a protein extract when a SM that inhibits the activity of interest is added. Fractions of uninhibited extract are added to the inhibited extract to identify the fraction that suppresses the SM's inhibitory activity. This process is repeated until the protein that suppresses the inhibition is purified and identified by gel electrophoresis and mass spectrometry (Fig. 22) (Terstappen et al. 2007 ).
The major advantages of this approach are that it does not require modification of the SM and small amounts of proteins can be identified because this method is not based on affinity. Furthermore, suppressors are introduced as native protein forms rather than individual gene products, allowing for identification not only of the target proteins but also of other pathway components (Terstappen et al. 2007) . However, this method needs to use protein fractions which is a drawback for intact cells which would need to be permeabilized (Terstappen et al. 2007) .
Although this approach might be a good alternative to affinity-based methods, to our knowledge, it has only been identified the Cdc42-RhoGDI (Rho-GDP dissociation inhibitor) complex as a direct target of pirl1 (Fig. 23 ) and the Arp 2/3 (actin and related proteins) complex as a downstream component of the actin assembly pathway that is capable of relieving upstream inhibition of Cdc42-RhoGDI when it is added at high concentrations (Peterson et al. 2006 ).
Target validation assays
Once a target protein is identified, the next step is to make certain that its modulation is associated with the phenotype observed in the assay where the SM was identified (Terstappen et al. 2007 ). There are several of approaches and tools available to discriminate between true interactions and false positives (Kramer and Cohen 2004 ) of which we would highlight bioinformatic analysis, if the three-dimensional protein structure is available (Macchiarulo et al. 2004; Mueller et al. 2007) , study of the physical interaction of the SM and the putative target by surface plasmon resonance (Boozer et al. 2006; Elinder et al. 2011; O'Connell et al. 2010) , fluorescence anisotropy (Zhang et al. 2011) , isothermal titration calorimetry (Buurman et al. 2011; Zhou et al. 2008) or resonance acoustic profiling (Li et al. 2006 ) and the use of cell culture validation experiments such as RNA interference (RNAi) and overexpression of the target protein.
Concluding remarks and future prospects
NPs play an important role in the discovery of new drugs and agrochemicals owing to their great chemical diversity, high affinity and specificity for biological targets. Understanding the mechanism of action of bioactive compounds and identifying their molecular targets, are still the most important challenges facing chemical genetics. Despite the great variety of new methods that have been developed over the last several years, affinity chromatography is still the most widespread and successful method for identifying the target proteins of bioactive-small molecules. Proof of this is the disproportionately large number of target proteins identified by affinity chromatography highlighted in this review in comparison with the rest of the techniques.
Recent advances in mass-spectrometry proteomic methods such as SILAC, ICAT and iTRAQ, together with proteomic approaches such as 2D-PAGE, DIGE or MudPIT, have enabled a distinction to be drawn between specific and nonspecific binders and will help to identify low abundance targets with a low-affinity small molecule by affinity chromatography. Moreover, subcellular localization of the small molecule by means of fluorescence probe could be used for affinity purification in order to decrease sample complexity.
However, affinity chromatography is limited to SM that contain derivatizable functionalities and whose bioactivity is unaffected by modification, which is a serious hurdle. Future advances in new techniques should avoid the derivatization or labelling of SMs and should allow their application to protein extracts and membrane proteins.
In this context, DARTS has emerged as a promising alternative to circumvent the drawbacks outlined above. Nevertheless, new experimental conditions and new advances in degradomics must be developed in order to decrease the number of proteolysis conditions that need to be tested for each SM. Freelabel protein microarrays could be used simultaneously with DARTS to study a whole proteome. Further identification of new target proteins using these approaches will prove whether they are suited for widespread use.
